Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

The fair value of stock options granted during 2018 were estimated with the following assumptions:

First Quarter:

Expected life	6.0 years
Risk-free interest rate		2.60	%
Expected annual volatility		113.87	%
Dividend yield		0.00	%

Second Quarter: 

Expected life	6.0 years
Risk-free interest rate		2.77	%
Expected annual volatility		108.59	%
Dividend yield		0.00	%

Share-based Compensation, Stock Options, Activity [Table Text Block]

For the six months ended June 30, 2018 option activity was as follows:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value
Outstanding at January 1, 2018		2,176,637		$	1.25		9.00
Granted		2,001,250			1.74		9.53
Exercised		(125,000	)		.17		5.87
Forfeited		(45,000	)		1.61		9.75
Outstanding at June 30, 2018		4,007,887		$	1.53		9.28	$	90,000
Exercisable at June 30, 2018		752,146		$	1.33		8.48	$	31,000

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]

The following table summarizes certain information about stock options for the six months ended June 30, 2018:

Weighted average grant-date fair value for options granted during the period	$	1.74
Vested options in-the-money at June 30, 2018		752,146
Aggregate intrinsic value of options exercised during the period	$	124,000

Common Stock Shares Reserved For Future Issuance [Table Text Block]

The following table summarizes the common shares reserved for future issuance under the Plan as of June 30, 2018:

Stock options outstanding	3,982,887
Stock options available for future grant	1,017,113
	5,000,000

Schedule of Other Share-based Compensation, Activity [Table Text Block]

For the six months ended June 30, 2018 option activity was as follows:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value
Outstanding at January 1, 2018		2,176,637		$	1.25		9.00
Granted		2,001,250			1.74		9.53
Exercised		(125,000	)		.17		5.87
Forfeited		(45,000	)		1.61		9.75
Outstanding at June 30, 2018		4,007,887		$	1.53		9.28	$	90,000
Exercisable at June 30, 2018		752,146		$	1.33		8.48	$	31,000

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The impact on our results of operations of recording stock-based compensation expense for the three months ended June 30, 2018 was as follows:

	Restricted				Channel
	Stock at		Stock		Partner
	Inception		Options		Warrants		Total
Cost of revenue	$	-	$	-	$	-	$	-
Research and development		-		1,184		-		1,184
General and administrative		381,287		179,032		-		560,319
	$	381,287	$	180,216		-	$	561,503

The impact on our results of operations of recording stock-based compensation expense for the three months ended June 30, 2017 was as follows:

	Restricted				Channel
	Stock at		Stock		Partner
	Inception		Options		Warrants		Warrants		Total
Cost of revenue	$	-	$	-	$	80,000	$	-	$	80,000
Research and development		-		-		-		-		-
General and administrative		269,341		176,016		-		32,335		477,692
	$	269,341	$	176,016		80,000		32,335	$	557,692

The impact on our results of operations of recording stock-based compensation expense for the six months ended June 30, 2018 was as follows:

	Restricted				Channel
	Stock at		Stock		Partner
	Inception		Options		Warrants		Total
Cost of revenue	$	-	$	-	$	136,586	$	136,586
Research and development		-		1290		-		1,290
General and administrative		1,393,862		380,656		-		1,774,518
	$	1,393,862	$	381,946		136,586	$	1,912,394

The impact on our results of operations of recording stock-based compensation expense for the six months ended June 30, 2017 was as follows:

	Restricted				Channel
	Stock at		Stock		Partner
	Inception		Options		Warrants		Warrants		Total
Cost of revenue	$	-	$	-	$	-	$	-	$	-
Research and development		-		-		-		-		-
General and administrative		539,994		191,512		80,000		32,335		843,841
	$	539,994	$	191,512		80,000		32,335	$	843,841